Featured Research

from universities, journals, and other organizations

OHSU Researchers Discover Breast Cancer Gene Inhibitor

Date:
September 15, 1999
Source:
Oregon Health Sciences University
Summary:
Researchers at Oregon Health Sciences University and the Vollum Institute have discovered a naturally occurring protein that inhibits the functions of the HER-2 oncogene, a major factor in breast and other cancers.

After Years of Study, Protein is Found that Blocks Activity of HER-2 Gene

Portland, Ore. - Researchers at Oregon Health Sciences University and the Vollum Institute have discovered a naturally occurring protein that inhibits the functions of the HER-2 oncogene, a major factor in breast and other cancers. The protein, dubbed herstatin, blocks the HER-2 signaling activity that causes tumor cells to grow, ultimately killing those cells. The findings are reported in the September issue of Proceedings of the National Academy of Sciences.

"This particular gene, HER-2, has such a clear-cut role in breast cancer that if you can inhibit its biochemical activity, you should be able to control the cancer," said Gail Clinton, Ph.D., associate professor of biochemistry and molecular biology at OHSU's School of Medicine.

Clinton and her former student, Joni Doherty, M.D., Ph.D., discovered herstatin while investigating the reasons why HER-2 acts so aggressively in tumor development. An overabundance of HER-2 is present in 25 to 30 percent of breast cancer cases and results in significantly lower survival rates and shorter time to relapse. Besides breast cancer, HER-2 is strongly linked to ovarian, gastric, endometrial and salivary gland cancers and possibly to prostate and colon cancers.

Although the HER-2 oncogene was discovered nearly 20 years ago, and has been studied intensely by scientists around the world, herstatin is the first naturally occurring molecule found to inhibit HER-2. During their research, Clinton and Doherty uncovered a novel mechanism for generation of a HER-2 binding protein resulting in the discovery of herstatin. Because their work involved human cells in culture, there is promise that the protein can be developed into a treatment.

"It's a long way from cells in culture to treating patients, but we are very optimistic about our findings," Clinton said. In addition to Doherty, who is now a surgical fellow at the University of Southern California, other researchers involved were John Adelman, Ph.D., and Chris Bond, M.S., of the Vollum Institute and Armando Jardim, Ph.D., of OHSU.


Story Source:

The above story is based on materials provided by Oregon Health Sciences University. Note: Materials may be edited for content and length.


Cite This Page:

Oregon Health Sciences University. "OHSU Researchers Discover Breast Cancer Gene Inhibitor." ScienceDaily. ScienceDaily, 15 September 1999. <www.sciencedaily.com/releases/1999/09/990915080618.htm>.
Oregon Health Sciences University. (1999, September 15). OHSU Researchers Discover Breast Cancer Gene Inhibitor. ScienceDaily. Retrieved October 21, 2014 from www.sciencedaily.com/releases/1999/09/990915080618.htm
Oregon Health Sciences University. "OHSU Researchers Discover Breast Cancer Gene Inhibitor." ScienceDaily. www.sciencedaily.com/releases/1999/09/990915080618.htm (accessed October 21, 2014).

Share This



More Health & Medicine News

Tuesday, October 21, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

CDC Revamps Ebola Guidelines After Criticism

CDC Revamps Ebola Guidelines After Criticism

Newsy (Oct. 21, 2014) The Centers for Disease Control and Prevention have issued new protocols for healthcare workers interacting with Ebola patients. Video provided by Newsy
Powered by NewsLook.com
WHO: Ebola Vaccine Trials to Start a in January

WHO: Ebola Vaccine Trials to Start a in January

AP (Oct. 21, 2014) Tens of thousands of doses of experimental Ebola vaccines could be available for "real-world" testing in West Africa as soon as January as long as they are deemed safe in soon to start trials, the World Health Organization said Tuesday. (Oct. 21) Video provided by AP
Powered by NewsLook.com
First-Of-Its-Kind Treatment Gives Man Ability To Walk Again

First-Of-Its-Kind Treatment Gives Man Ability To Walk Again

Newsy (Oct. 21, 2014) A medical team has for the first time given a man the ability to walk again after transplanting cells from his brain onto his severed spinal cord. Video provided by Newsy
Powered by NewsLook.com
CDC Issues New Ebola Guidelines for Health Workers

CDC Issues New Ebola Guidelines for Health Workers

Reuters - US Online Video (Oct. 21, 2014) The U.S. Centers for Disease Control and Prevention has set up new guidelines for health workers taking care of patients infected with Ebola. Linda So reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins